Literature DB >> 2841996

The serotonin type 3 receptor antagonist BRL 43694 and nausea and vomiting induced by cisplatin.

J Carmichael1, B M Cantwell, C M Edwards, W G Rapeport, A L Harris.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841996      PMCID: PMC1833825          DOI: 10.1136/bmj.297.6641.110

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin.

Authors:  M G Kris; R J Gralla; R A Clark; L B Tyson; J P O'Connell; M S Wertheim; D P Kelsen
Journal:  J Clin Oncol       Date:  1985-10       Impact factor: 44.544

2.  Blockade of neuronal tryptamine receptors by metoclopramide.

Authors:  J R Fozard; A T Mobarok ALI
Journal:  Eur J Pharmacol       Date:  1978-05-01       Impact factor: 4.432

3.  Prevention of emesis in patients receiving cytotoxic drugs by GR38032F, a selective 5-HT3 receptor antagonist.

Authors:  D Cunningham; J Hawthorn; A Pople; J C Gazet; H T Ford; T Challoner; R C Coombes
Journal:  Lancet       Date:  1987-06-27       Impact factor: 79.321

4.  Extrapyramidal reactions with metoclopramide.

Authors:  D N Bateman; M D Rawlins; J M Simpson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-05
  4 in total
  17 in total

1.  Differential interactions of traditional and novel antiemetics with dopamine D2 and 5-hydroxytryptamine3 receptors.

Authors:  A Hamik; S J Peroutka
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Topographical distribution of 5-HT3 receptor recognition sites in the ferret brain stem.

Authors:  J M Barnes; N M Barnes; B Costall; I L Naylor; R J Naylor; J A Rudd
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-07       Impact factor: 3.000

Review 3.  5-HT3 receptor antagonists. An overview of their present status and future potential in cancer therapy-induced emesis.

Authors:  M S Aapro
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

4.  The effects of gamma-radiation on intestinal motor activity and faecal pellet expulsion in the guinea pig.

Authors:  A Krantis; K Rana; R K Harding
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

Review 5.  Pharmacological Agents Affecting Emesis : A Review (Part II).

Authors:  F Mitchelson
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

6.  A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: correlation with anti-emetic response.

Authors:  J Carmichael; B M Cantwell; C M Edwards; B D Zussman; S Thompson; W G Rapeport; A L Harris
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

7.  The antiemetic activity of granisetron against cytostatic-treatment-induced emesis in 10- to 13-week-old ferrets.

Authors:  H E Marr; P T Davey; E A Boyle; P R Blower
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

Review 8.  [Management of chemotherapy-induced emesis: what is the standard after 20 years of clinical research].

Authors:  A Du Bois
Journal:  Med Klin (Munich)       Date:  1998-01

Review 9.  Volunteer models for predicting antiemetic activity of 5-HT3-receptor antagonists.

Authors:  N A Minton
Journal:  Br J Clin Pharmacol       Date:  1994-06       Impact factor: 4.335

Review 10.  Reducing chemotherapy-induced nausea and vomiting. Current perspectives and future possibilities.

Authors:  A Del Favero; F Roila; M Tonato
Journal:  Drug Saf       Date:  1993-12       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.